Billions at stake as Covid boosters roll out
The United States weighs wider booster use for Pfizer and Moderna vaccines. Analysts project billions in potential revenue as officials endorse boosters for seniors and high risk groups, with CVS and Walgreens seen profiting from expanded distribution.
MENTIONED IN THIS ARTICLE
U.S
Moderna
Johnson & Johnson
Pfizer
Jefferies
Michael Yee
Wall Street
Joe Biden
Germany
Biontech
Morningstar
Karen Andersen
Britain
Andersen
J&j
Europe
AstraZeneca
WBB Securities
Steve Brozak
CVS Health
Walgreens
Jeff Jonas
Gabelli
Jonas
AbbVie
Erik Gordon
University of Michigan
Gordon
Rogelio V. Solis
Also Mentioned on This Page
Pfizer Futures
Associated Press Health and Science Department
Howard Hughes Medical Institute
Department of Science Education
The
Spe
Biontech T
Holland & Holland Farmers Market
Windmill Island Artisan Market
Crown ‘Ac
Honda
Owntown
Olland
Sita Dealers
Bigge Jcoffe
Hollandfallfest
Basu En En
Fubmichigan.com
Greg Accardo
Tamara Milohinski
CTF
Jesse Prins
Cynthia Lamirande
First National Bank Omerie
West 8Th St
Holland